Xiamen Amoytop Biotech Co., Ltd.

SHSE:688278 Stock Report

Market Cap: CN¥30.0b

Xiamen Amoytop Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 688278?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme4,000,0000.983%
Private Companies20,200,0534.97%
Institutions55,230,07613.6%
General Public55,299,88313.6%
Public Companies65,200,11416%
Individual Insiders206,869,87450.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 83.07% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
33.9%
Ying Yang
138,077,266CN¥10.2b0%no data
16%
Tonghua Dongbao Pharmaceutical Co., Ltd.
65,200,114CN¥4.8b0%no data
10.8%
Li Sun
43,967,358CN¥3.2b0%no data
4.98%
Guojin Dingxing Investment Co., Ltd.
20,250,000CN¥1.5b0%100.0%
4.97%
Guangzhou Houbao Investment Partnership Enterprise (Limited Partnership)
20,200,053CN¥1.5b0%no data
2.25%
Shanxian Zheng
9,165,788CN¥676.7m-0.39%no data
1.32%
Zhonghong Zuo
5,367,953CN¥396.3m0%no data
0.98%
Xiamen Amoytop Biotech Co., Ltd., ESOP
4,000,000CN¥295.3m0%no data
0.97%
China Merchants Fund Management Company Ltd.
3,932,246CN¥290.3m0%0.17%
0.9%
Dacheng Fund Management Co., Ltd.
3,668,443CN¥270.8m0%0.23%
0.77%
Shanghai Orient Securities Asset Management Co., Ltd.
3,125,020CN¥230.7m0%0.26%
0.45%
Bosera Asset Management Co., Ltd.
1,833,448CN¥135.4m0%0.08%
0.45%
HuaAn Fund Management Company Ltd.
1,832,655CN¥135.3m0%0.07%
0.43%
Penghua Fund Management Co., Ltd.
1,754,837CN¥129.6m0%0.11%
0.38%
Zhili Sun
1,556,746CN¥114.9m0%no data
0.38%
Fanghe Chen
1,549,899CN¥114.4m0%no data
0.38%
Yinhua Fund Management Co., Ltd.
1,536,962CN¥113.5m0%0.1%
0.36%
GF Fund Management Co., Ltd.
1,482,666CN¥109.5m0%0.03%
0.36%
Linzhong Zhang
1,466,228CN¥108.3m0%no data
0.34%
Guotai Asset Management Company Limited
1,400,402CN¥103.4m0%0.05%
0.34%
Fullgoal Fund Management Co. Ltd.
1,372,002CN¥101.3m0%0.04%
0.33%
Liping Lai
1,335,567CN¥98.6m0%no data
0.32%
Tianhong Asset Management Co., Ltd.
1,291,824CN¥95.4m0%0.06%
0.31%
China Southern Asset Management Co., Ltd.
1,275,815CN¥94.2m0%0.03%
0.31%
Meihua Yang
1,272,586CN¥94.0m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 11:08
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xiamen Amoytop Biotech Co., Ltd. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hao WuChasing Securities
Pei ChengChina Galaxy Securities Co., Ltd.
Feifei XuChina Merchants Securities Co. Ltd.